bpc 157 regulatory fda warning Here's a nice graphic on BPC-157 that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D bpc-157 safety regulatory status fda
Description
Not every long COVID patient is an appropriate candidate for peptide therapy and that's okay
BPC-157 and TB-500 operate through distinct but complementary mechanisms
Pricing and stock availability may vary in-store
Normal is not optimal
Research shows systemic effects require milligram-range dosing for GHK-Cu, while BPC-157 and TB-500 show activity at lower concentrations
